Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|January 29, 2008
Gamma-secretase modulation and its promise for Alzheimer's disease: a rationale for drug discoveryDirk BeherAlzheimer'S Research & Therapy|April 13, 2012
Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's diseaseSascha Weggen, Dirk BeherCurrent Pharmaceutical Design|October 28, 2005
Gamma-secretase as a therapeutic target for the treatment of Alzheimer's diseaseIan Churcher, Dirk BeherExpert Opinion on Investigational Drugs|November 1, 2005
Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's diseaseDirk Beher, Samuel L GrahamCurrent Pharmaceutical Design|November 16, 2006
Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyondStefanie Leuchtenberger, Dirk Beher, Sascha WeggenCurrent Opinion in Drug Discovery & Development|October 27, 2004
gamma-Secretase as a target for drug intervention in Alzheimer's diseaseTimothy Harrison, Ian Churcher, Dirk BeherJournal of Neurochemistry|August 3, 2002
Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activityDirk Beher, Jonathan D J Wrigley, Andrew P Owens, et al.The Journal of Biological Chemistry|January 31, 2003
gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid betaHeike S Grimm, Dirk Beher, Stefan F Lichtenthaler, et al.Journal of Lipid Research|September 18, 2004
Fatty acids increase presenilin-1 levels and [gamma]-secretase activity in PSwt-1 cellsYanzhu Liu, Lin Yang, Karin Conde-Knape, et al.The Journal of Biological Chemistry|December 14, 2004
Gamma-secretase complex assembly within the early secretory pathwayAnja Capell, Dirk Beher, Stefan Prokop, et al.Pageof 4